Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2017; Elsevier BV; Volume: 130; Linguagem: Inglês
10.1182/blood.v130.suppl_1.577.577
ISSN1528-0020
AutoresStephen J. Schuster, Michael Bishop, Constantine S. Tam, Edmund K. Waller, Peter Borchmann, Joseph P. McGuirk, Ulrich Jaeger, Samantha Jaglowski, Charalambos Andreadis, Jason R. Westin, Isabelle Fleury, Veronika Bachanová, S.R. Foley, P. Joy Ho, Stephan Mielke, John Magenau, Harald Holte, Koen van Besien, Marie José Kersten, Takanori Teshima, Kensei Tobinai, Paolo Corradini, Oezlem Anak, Lida Pacaud, Christopher del Corral, Rakesh Awasthi, Feng Tai, Gilles Salles, Richard T. Maziarz,
Tópico(s)Chronic Lymphocytic Leukemia Research
Referência(s)